Evaluating the Mediterranean diet in patients with kidney stones and bone diseases
Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
This study is testing how well people with kidney stones and bone diseases stick to the Mediterranean diet to see if it can help manage their conditions better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Irccs Synlab Sdn Academic / other |
| Locations | 1 site (Naples) |
| Trial ID | NCT06869603 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how well patients with recurrent kidney stones and osteometabolic diseases adhere to the Mediterranean diet. By evaluating dietary habits, the study seeks to gather crucial data that can inform dietary management strategies for these conditions. The findings may help in developing effective dietary approaches for the prevention of recurrent kidney stones and related health issues. The study will involve patients who have experienced multiple kidney stones in the past five years.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with idiopathic relapsing nephrolithiasis who have had evidence of bilateral renal stones or multiple stones in the past five years.
Not a fit: Patients with certain medical conditions, such as high calcium levels or severe kidney impairment, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved dietary recommendations that help prevent recurrent kidney stones and manage osteometabolic diseases.
How similar studies have performed: While there is existing research on dietary impacts on kidney stones, this specific evaluation of the Mediterranean diet in this patient population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years Exclusion Criteria: * Patients who had albumin-corrected plasma calcium levels \> 11.0 mg/dl at the time of the first determination of serum levels of 25 OH vitamin D; * Patients who had glomerular filtration rate \< 60 mL/min/1.73 m2; * Patients who had positive personal history of chronic granulomatous disease; * pregnancy patients; * Positive personal history for morphological abnormalities of the excretory system; * incomplete data collection.
Where this trial is running
Naples
- Irccs Synlab Sdn — Naples, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.